Published in Gene Therapy Weekly, June 2nd, 1997
A genetic disorder that can lead to a severe and potentially lethal form of emphysema is surprisingly common, according to a recent report of the World Health Organization (WHO). Based on its estimated gene frequency, the disorder - known as alpha1-antitrypsin deficiency (A1AD) - is one of the most prevalent hereditary disorders among people of Northern European descent. A1AD may affect as many as 100,000 Americans, but only a small number have been diagnosed.
Bayer Corporation is supporting a major new clinical research initiative and a global awareness campaign to address two...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.